Haptoglobin and Preeclampsia
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to show that a certain protein called haptoglobin protects against preeclampsia which is a common pregnancy complication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2009
CompletedFirst Posted
Study publicly available on registry
December 7, 2009
CompletedDecember 7, 2009
December 1, 2009
December 4, 2009
December 4, 2009
Conditions
Study Arms (2)
healthy control
240 female subjects without preeclampsia
preeclampsia
120 female subjects with preeclampsia
Eligibility Criteria
women coming to give birth at our medical center
You may qualify if:
- all women
You may not qualify if:
- women with hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bnai-Zion Medical Center
Haifa, 33393, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
December 4, 2009
First Posted
December 7, 2009
Last Updated
December 7, 2009
Record last verified: 2009-12